Ambrosia - SupHerb Ltd.   Report issue

For profit
Founded: Netanya Israel (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
2005
NCT00312910
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Ambrosia - SupHerb Ltd.

Active Ingredients

Drugs in Other Trials (3)

autologous microbiome (1 trial)

sodium chloride (1 trial)

solgar no7 complex (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 3